:GBR-13119

{{Chembox

| ImageFile = GBR-13119.svg

| ImageSize = 200px

| PIN = 1-[2-(Diphenylmethoxy)ethyl]-4-[3-(4-fluorophenyl)propyl]piperazine

| OtherNames =

|Section1={{Chembox Identifiers

| CASNo = 76778-23-9

| CASNo_Ref = {{Cascite|changed|EPA}}

| ChEMBL = 288914

| PubChem = 131286

| ChemSpiderID = 116058

| SMILES = C1CN(CCN1CCCC2=CC=C(C=C2)F)CCOC(C3=CC=CC=C3)C4=CC=CC=C4

| InChI = 1/C28H33FN2O/c29-27-15-13-24(14-16-27)8-7-17-30-18-20-31(21-19-30)22-23-32-28(25-9-3-1-4-10-25)26-11-5-2-6-12-26/h1-6,9-16,28H,7-8,17-23H2

| InChIKey = IYWFOWPCJVOCMB-UHFFFAOYAU

| StdInChI = 1S/C28H33FN2O/c29-27-15-13-24(14-16-27)8-7-17-30-18-20-31(21-19-30)22-23-32-28(25-9-3-1-4-10-25)26-11-5-2-6-12-26/h1-6,9-16,28H,7-8,17-23H2

| StdInChIKey = IYWFOWPCJVOCMB-UHFFFAOYSA-N

}}

|Section2={{Chembox Properties

| C=28 | H=33 | F=1 | N=2 | O=1

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility =

}}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt =

}}

}}

GBR-13119 is a psychostimulant and dopamine re-uptake inhibitor.{{cite journal|last=Kilbourn|first=Michael R.|author2=Phil S. Sherman |author3=Teresa Pisani |year=1992|title=Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site|journal=European Journal of Pharmacology|volume=216|issue=1|pages=109–112|issn=0014-2999|doi=10.1016/0014-2999(92)90216-Q|pmid=1526249|hdl=2027.42/30038|url=https://deepblue.lib.umich.edu/bitstream/2027.42/30038/1/0000406.pdf|hdl-access=free}}